Merrimack Pharmaceuticals Inc (MACK)
14.67
-0.01
(-0.07%)
USD |
NASDAQ |
Apr 16, 16:00
14.67
0.00 (0.00%)
After-Hours: 19:31
Merrimack Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | 70.50% |
| September 30, 2015 | -259.1% |
| June 30, 2015 | -62.31% |
| March 31, 2015 | -234.2% |
| December 31, 2014 | -28.60% |
| September 30, 2014 | -99.64% |
| June 30, 2014 | -65.11% |
| March 31, 2014 | -211.6% |
| December 31, 2013 | -422.6% |
| September 30, 2013 | -578.0% |
| June 30, 2013 | -163.0% |
| March 31, 2013 | -192.1% |
| Date | Value |
|---|---|
| December 31, 2012 | -174.5% |
| September 30, 2012 | -204.9% |
| June 30, 2012 | -166.0% |
| March 31, 2012 | -205.3% |
| December 31, 2011 | -144.0% |
| September 30, 2011 | -216.7% |
| June 30, 2011 | -440.5% |
| March 31, 2011 | -208.3% |
| December 31, 2010 | -160.0% |
| September 30, 2010 | -238.9% |
| June 30, 2010 | -308.5% |
| March 31, 2010 | -329.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |